What is PMN's revenue growth forecast for 2029-2029?
(NASDAQ: PMN) Promis Neurosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.
Promis Neurosciences's revenue in 2025 is $0.
In 2029, PMN is forecast to generate $3,459,823,870 in revenue, with the lowest revenue forecast at $3,459,823,870 and the highest revenue forecast at $3,459,823,870.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.